Unblinded HRI Data

It is always greatly appreciated when sponsors provide CenExel HRI with our unblinded data for their respective clinical trials, as well as permit us to report these data to others. The below are examples of our unblinded data on various trials. We are happy to continue reporting these findings when sponsors provide the information and permit us to share the data on our website. If you have any questions about these results, please email Dr. Elan Cohen, Principal Investigator at CenExel HRI, at e.cohen@cenexel.com.

HRI 2016 Acute Inpatient Phase 3 Placebo-Controlled Double-Blind Schizophrenia Results

Separation between drug and Placebo.

Learn More

hri-2016

hri-2016

HRI 2017 Phase 3 Allergan RGH-MD-54 Outpatient Placebo-Controlled Double-Blind Bipolar Depression Results

Separation between drug and Placebo.

Learn More

HRI 2018 Phase 2 Inpatient Placebo-Controlled Double-Blind Acute Schizophrenia Results

Separation Between Drug and Placebo.

Learn More

hri-2018

See If You Qualify
Learn More About Our
Open Studies

Contact Us Now